Skip to main content
Year archive

SAMSUNG PHARMACEUTICAL.CO.,Ltd. — 2019 filings

All 23 regulatory filings released by SAMSUNG PHARMACEUTICAL.CO.,Ltd. (001360) in 2019, sourced directly from the official regulator.

23 Filings
2019 Period
2019 filings (23)
Filing Released Lang
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-12-05 Korean
합병등종료보고서(합병)
M&A Activity
2019-11-26 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-11-12 Korean
기타경영사항(자율공시)(소규모합병 승인이사회(주주총회 갈음) 결의)
M&A Activity
2019-10-23 Korean
조회공시요구(현저한시황변동)에대한답변(중요공시대상없음)
Regulatory Filings
2019-10-17 Korean
조회공시요구(현저한시황변동)
Regulatory Filings
2019-10-16 Korean
해산사유발생(자율공시)(종속회사의주요경영사항)
Capital/Financing Update
2019-09-20 Korean
[첨부추가]주요사항보고서(회사합병결정)
M&A Activity
2019-09-20 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-06-18 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-05-15 Korean
타법인주식및출자증권취득결정
Capital/Financing Update
2019-04-23 Korean
신규시설투자등
Capital/Financing Update
2019-04-17 Korean
사업보고서 (2018.12)
Interim / Quarterly Report FY 2018
2019-04-01 Korean
정기주주총회결과(제65기)
Declaration of Voting Results & Voting Rights Announcements
2019-03-27 Korean
감사보고서제출
Audit Report / Information FY 2018
2019-03-19 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2019-03-12 Korean
주주총회소집결의
AGM Information
2019-03-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports
2019-03-08 Korean
주주총회집중일개최사유신고
Regulatory Filings
2019-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2019-03-08 Korean
유형자산처분결정
Capital/Financing Update
2019-01-22 Korean